Mundipharma strengthens its portfolio by offering medicines for the treatment of asthma; One of the most common chronic diseases in the world, associated with high mortality rates.
Introducing to the Argentine market this new and unique therapeutic option in asthma, we are sure to contribute to better control of the disease.